Literature DB >> 18691764

Use of the rabbit with a failing heart to test for torsadogenicity.

Robert L Hamlin1, Anusak Kijtawornrat.   

Abstract

Torsades de pointes is a potentially lethal arrhythmia that occurs infrequently but may be drug-induced particularly in patients with pathological substrates. However drugs are usually evaluated for torsadogenicity in normal subjects, thus potentially limiting the sensitivity of studies to predict liability in man. Heart failure is a pathological substrate permissive to drug-induced torsades de pointes. Failing hearts may be produced with a high yield in rabbits with ligation of coronary arteries. Failing myocardium may be documented by reduced left ventricular ejection fraction and elevation of NTproBNP. QTc in failing hearts prolonged only slightly more in failing hearts than in normals in response to torsadogens, but incidence of torsades de pointes increased dramatically. Abnormal calcium cycling resulting in early afterdepolarizations appeared to develop more in hypertrophic myocardial cells located in the border between normal myocardium and infarct. In failing hearts, torsades de pointes appeared to develop more prevalently without greater lengthening of QT than in hearts from normal rabbits. Thus this model appears to be a facile and useful preparation for identifying torsadogenic potential of test articles, and it probably possesses anatomical and physiological substrates that mimic closely the torsadogenic substrates in the many millions of persons possessing failing hearts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691764     DOI: 10.1016/j.pharmthera.2008.03.011

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  5 in total

1.  Cardiac imaging and safety evaluation of BMS747158, a novel PET myocardial perfusion imaging agent, in chronic myocardial compromised rabbits.

Authors:  Ming Yu; Jody Bozek; Mary Guaraldi; Mikhail Kagan; Michael Azure; Simon P Robinson
Journal:  J Nucl Cardiol       Date:  2010-03-26       Impact factor: 5.952

2.  Robust anti-arrhythmic efficacy of verapamil and flunarizine against dofetilide-induced TdP arrhythmias is based upon a shared and a different mode of action.

Authors:  A Oros; M J Houtman; P Neco; A M Gomez; S Rajamani; P Oosterhoff; N J Attevelt; J D Beekman; M A G van der Heyden; L Ver Donck; L Belardinelli; S Richard; G Antoons; M A Vos
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 3.  Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.

Authors:  Attila S Farkas; Stanley Nattel
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

4.  An increasing electromechanical window is a predictive marker of ventricular fibrillation in anesthetized rabbit with ischemic heart.

Authors:  Vudhiporn Limprasutr; Prapawadee Pirintr; Anusak Kijtawornrat; Robert L Hamlin
Journal:  Exp Anim       Date:  2017-11-21

Review 5.  Rabbit models of heart disease.

Authors:  Steven M Pogwizd; Donald M Bers
Journal:  Drug Discov Today Dis Models       Date:  2009-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.